Ji-young Lim
Seoul St. Mary's Hospital
Seoul, Republic of Korea
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Insulin Signalling-Inducible IFITM1 Promotes Multiple Myeloma Progression and Bortezomib Resistance.
Insulin Signalling-Inducible IFITM1 Promotes Multiple Myeloma Progression and Bortezomib Resistance.
Journal: Journal of cellular and molecular medicine
Published: December 17, 2024
Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases.
Journal: Annals of laboratory medicine
Published: August 11, 2024
Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness.
Journal: Experimental & molecular medicine
Published: May 19, 2022
Predictive Models for Nurses' Entrepreneurial Intentions Using Comparison of Competing Models.
Journal: International journal of environmental research and public health
Published: April 14, 2022
Factors Associated with Job Stress among Hospital Nurses: A Meta-Correlation Analysis.
Journal: International journal of environmental research and public health
Published: April 01, 2022
Development and Evaluation of the "High-Up" Program for Enhancing the Nursing-Management Competency of Mid-Career Hospital Nurses: A Quasi-Experimental Study.
Journal: International journal of environmental research and public health
Published: February 24, 2022
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone.
Journal: Experimental hematology
Published: February 14, 2022
Nursing Students' Subjective Happiness: A Social Network Analysis.
Journal: International journal of environmental research and public health
Published: August 30, 2021
A Systematic Review and Meta-Analysis of Fall Prevention Programs for Pediatric Inpatients.
Journal: International journal of environmental research and public health
Published: February 08, 2021
Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease.
Journal: Experimental hematology
Published: September 10, 2020
Myeloma-Secreted Galectin-1 Potently Interacts with CD304 on Monocytic Myeloid-Derived Suppressor Cells.
Journal: Cancer immunology research
Published: August 13, 2020
Last Updated: 09/26/2026